MKSAP 17 Audio Companion - Pulmonary Medicine

• MKSAP_17_Audio_Companion_Pulmonary.pdf
• 1-01 Introduction to Pulmonary Medicine Section.m4a
• 1-02 Pulmonary Function Testing and Spirometry.m4a
• 1-03 Bronchial Challenge Testing and Lung Volumes.m4a
• 1-04 DLCO, 6-Minute Walk Test and Pulse Oximetry.m4a
• 1-05 Chest Radiography and Computed Tomography.m4a
• 1-06 Session MCQ 1 Item 06 A 60-year-old Woman is Seen for Worsening Dyspnea.m4a
• 1-07 Positron Emission Tomography and Bronchoscopy.m4a
• 1-08 Common Indications for Diagnostic Bronchoscopy.m4a
• 1-09 Epidemiology and Natural History of Asthma.m4a
• 1-10 Pathogenesis and Risk Factors.m4a
• 1-11 Symptoms and Clinical Evaluation.m4a
• 1-12 Session MCQ 2 Item 11 A 64-year-old Man is Seen for Shortness of Breath and a Cough.m4a
• 1-13 Asthma Syndromes.m4a
• 1-14 Occupational Asthma and Aspirin-Sensitive Asthma.m4a
• 1-15 Reactive Airways Dysfunction Syndrome and Virus-Induced Bronchospasm.m4a
• 1-16 Allergic Bronchopulmonary Aspergillosis.m4a
• 1-17 GERD, Sinus Disease and Obstructive Sleep Apnea.m4a
• 1-18 Session 1 Key Points.m4a
• 1-19 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 Vocal Cord Dysfunction.m4a
• 2-03 Obesity.m4a
• 2-04 Medications.m4a
• 2-05 Session MCQ 3 Item 15 A 59-year-old Man is Seen for Dyspnea.m4a
• 2-06 Controller Medications.m4a
• 2-07 Nonpharmacologic Therapy.m4a
• 2-08 Management of Asthma Exacerbations.m4a
• 2-09 Chronic Obstructive Pulmonary Disease.m4a
• 2-10 Session MCQ 4 Item 16 A 67-year-old Woman is Seen for Fever, Dyspnea, and Cough.m4a
• 2-11 Heterogeneity of COPD.m4a
• 2-12 Diagnosis.m4a
• 2-13 Assessment and Monitoring.m4a
• 2-14 GOLD Model for Classifying Severity of Disease in COPD.m4a
• 2-15 Chronic Management.m4a
• 2-16 Pharmacologic Treatment and Bronchodilators.m4a
• 2-17 Inhaled Glucocorticoids.m4a
• 2-18 Session 2 Key Points.m4a
• 2-19 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Systemic Glucocorticoids and Methylxanthines.m4a
• 3-03 Phosphodiesterase-4 Inhibitors and Antibiotics.m4a
• 3-04 Other Agents and Vaccination.m4a
• 3-05 Smoking Cessation and Pulmonary Rehabilitation.m4a
• 3-06 Session MCQ 5 Item 18 A 62-year-old Man is Admitted with Community-Acquired Pneumonia.m4a
• 3-07 Oxygen Therapy and Noninvasive Mechanical Ventilation.m4a
• 3-08 Lung Volume Reduction Surgery and Lung Transplantation.m4a
• 3-09 Acute Exacerbations of COPD.m4a
• 3-10 Initial Assessment and Setting of Care.m4a
• 3-11 Goals and Therapeutic Management and Palliative Care and Hospice.m4a
• 3-12 Session MCQ 6 Item 19 A 58-year-old Woman is Seen for Daily Wheezing and Breathlessness.m4a
• 3-13 Bronchiectasis.m4a
• 3-14 Presentation, Diagnosis and Treatment.m4a
• 3-15 Cystic Fibrosis in Adults.m4a
• 3-16 Treatment.m4a
• 3-17 Diffuse Parenchymal Lung Disease.m4a
• 3-18 Diagnostic Approach and Evaluation.m4a
• 3-19 Session 3 Key Points.m4a
• 3-20 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 High-Resolution CT Scanning.m4a
• 4-03 Diffuse Parenchymal Lung Diseases with a Known Cause.m4a
• 4-04 Connective Tissue Diseases.m4a
• 4-05 Hypersensitivity Pneumonitis.m4a
• 4-06 Drug-Induced and Radiation-Induced Parenchymal Lung Disease.m4a
• 4-07 Session MCQ 7 Item 24 A 57-year-old Woman is Evaluated for Exertional Dyspnea.m4a
• 4-08 Idiopathic Pulmonary Fibrosis.m4a
• 4-09 Nonspecific Interstitial Pneumonia.m4a
• 4-10 Cryptogenic Organizing Pneumonia and Acute Interstitial Pneumonia.m4a
• 4-11 Sarcoidosis and Lymphangioleiomyomatosis.m4a
• 4-12 Session MCQ 8 Item 25 A 44-year-old Woman is Seen for Worsening Asthma.m4a
• 4-13 Occupational Lung Disease.m4a
• 4-14 Management and Surveillance.m4a
• 4-15 Asbestos-Related Lung Disease.m4a
• 4-16 Asbestos-Related Pleural Diseases and Silicosis.m4a
• 4-17 Session 4 Key Points.m4a
• 4-18 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-02 Pleural Effusion.m4a
• 5-03 Diagnostic Imaging and Indications for Thoracentesis.m4a
• 5-04 Pleural Fluid Analysis.m4a
• 5-05 Cell Counts, Differential and Blood Chemistry Studies.m4a
• 5-06 Tests for Tuberculous Effusions and Pleural Malignancy.m4a
• 5-07 Session MCQ 9 Item 26 A 56-year-old Woman is Seen for Acute Respiratory Distress Syndrome.m4a
• 5-08 Management of Parapneumonic Effusions and Empyema.m4a
• 5-09 Malignant Pleural Effusion and Pneumothorax.m4a
• 5-10 Pulmonary Hypertension.m4a
• 5-11 Diagnosis and Treatment.m4a
• 5-12 Session MCQ 10 Item 30 A 42-year-old Man with Obstructive Sleep Apnea is Seen.m4a
• 5-13 Chronic Thromboembolic Pulmonary Hypertension.m4a
• 5-14 Pulmonary Arterial Hypertension.m4a
• 5-15 Diagnosis and Treatment.m4a
• 5-16 Pulmonary Nodule Evaluation.m4a
• 5-17 Types of Lung Cancer.m4a
• 5-18 Diagnosis, Staging and Screening.m4a
• 5-19 Preinvasive Lung Lesions.m4a
• 5-20 Session 5 Key Points.m4a
• 5-21 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Bronchial Carcinoid Tumors.m4a
• 6-03 Mesothelioma and Pulmonary Metastases.m4a
• 6-04 Mediastinal Masses.m4a
• 6-05 Excessive Daytime Sleepiness.m4a
• 6-06 Common Conditions that Disrupt Circadian Rhythm.m4a
• 6-07 Session MCQ 11 Item 31 A 61-year-old Woman is Seen for Fever, Shortness of Breath, and Weakness.m4a
• 6-08 Clinical Features, Diagnosis and Treatment.m4a
• 6-09 Positive Airway Pressure, Oral Appliances and Upper Airway Surgery.m4a
• 6-10 Central Sleep Apnea Syndromes.m4a
• 6-11 Session MCQ 12 Item 39 A 58-year-old Man is Seen for Cough, Wheezing, and Shortness of Breath.m4a
• 6-12 Sleep-Related Hypoventilation Syndromes.m4a
• 6-13 Sleep Disturbances and Periodic Breathing.m4a
• 6-14 Acute Mountain Sickness and High-Altitude Cerebral Edema.m4a
• 6-15 High-Altitude Pulmonary Edema and Air Travel in Pulmonary Disease.m4a
• 6-16 Session 6 Key Points.m4a
• 6-17 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Recognizing the Critically Ill Patient.m4a
• 7-03 General Ventilator Principles.m4a
• 7-04 Indications and Patient Selection.m4a
• 7-05 Application.m4a
• 7-06 Fundamental Concepts of Invasive Mechanical Ventilation.m4a
• 7-07 Weaning.m4a
• 7-08 Ventilator-Associated Pneumonia and Invasive Monitoring.m4a
• 7-09 Blood Pressure Support and Intravenous Access.m4a
• 7-10 Comprehensive Management of Critically Ill Patients.m4a
• 7-11 ICU-Acquired Weakness and Long-Term Cognitive Impairment.m4a
• 7-12 Postintensive Care Syndrome and Nutrition.m4a
• 7-13 ICU Care Bundles and High-Value Care in the ICU.m4a
• 7-14 Upper Airway Emergencies.m4a
• 7-15 Shock.m4a
• 7-16 Hypoxemic Respiratory Failure.m4a
• 7-17 Acute Respiratory Distress Syndrome and Ventilatory Management.m4a
• 7-18 Session 7 Key Points.m4a
• 7-19 Close to Session 7.m4a
• 8-01 Introduction to Session 8.m4a
• 8-02 Nonventilatory Management.m4a
• 8-03 Heart Failure and Atelectasis.m4a
• 8-04 Pneumonia and Decreased Respiratory Drive.m4a
• 8-05 Restrictive Lung Disease and Diffuse Parenchymal Lung Disease.m4a
• 8-06 Neuromuscular Weakness.m4a
• 8-07 Obstructive Lung Disease.m4a
• 8-08 Critical Care Management of Severe Asthma Exacerbation.m4a
• 8-09 Critical Care Management of COPD Exacerbation.m4a
• 8-10 Sepsis.m4a
• 8-11 Initial Resuscitation.m4a
• 8-12 Antibiotic Therapy, Source Control and Adjunctive Therapies.m4a
• 8-13 Smoke Inhalation.m4a
• 8-14 Other Forms of Inhalational Injury.m4a
• 8-15 Session 8 Key Points.m4a
• 8-16 Close to Session 8.m4a
• 9-01 Introduction to Session 9.m4a
• 9-02 Hypertensive Emergencies.m4a
• 9-03 Hyperthermic Emergencies and Heat Stroke.m4a
• 9-04 Malignant Hyperthermia.m4a
• 9-05 Toxicology and Alcohol Poisoning.m4a
• 9-06 Carbon Monoxide and Cyanide Poisoning.m4a
• 9-07 Toxicity of Drugs of Abuse.m4a
• 9-08 Therapeutic Drug Overdose.m4a
• 9-09 Acute Abdominal Surgical Emergencies.m4a
• 9-10 Anoxic Brain Injury.m4a
• 9-11 Session 9 Key Points.m4a
• 9-12 Close to Pulmonary Medicine Section.m4a